UroGen Pharma Ltd. (URGN)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

11.35

0.00%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Revenue	82.71M	64.36M	48.04M	11.80M	18.00K	1.13M	8.16M	17.53M	-	-	-
Cost of Revenue	9.36M	7.65M	5.16M	1.01M	-	1.80M	600.00K	28.00K	113.00K	-	-
Gross Profit	73.35M	56.70M	42.88M	10.79M	18.00K	-675.00K	7.56M	17.50M	-113.00K	-	-
Operating Income	-65.54M	-79.04M	-92.29M	-126.74M	-109.48M	-77.18M	-19.95M	798.00K	-12.41M	-4.37M	-3.39M
Interest Income	2.64M	1.01M	212.00K	1.63M	4.62M	1.87M	-	1K	-	120.00K	83.00K
Pretax Income	-98.32M	-108.03M	-109.37M	-125.11M	-105.15M	-75.53M	-19.98M	-1.94M	-12.69M	-4.48M	-3.31M
Net Income	-102.24M	-109.16M	-110.82M	-128.48M	-100.53M	-75.66M	-20.00M	-1.94M	-12.69M	-4.56M	-3.31M
Selling & General & Admin	93.27M	82.84M	87.53M	90.22M	60.20M	39.57M	8.81M	6.42M	1.90M	890.00K	1.05M
Research & Development	45.61M	52.91M	47.64M	47.31M	49.30M	36.93M	18.70M	10.29M	10.52M	4.01M	2.33M
Other Expenses	-	72.00K	-	-	-284.00K	-	-	-	-	-	-
Operating Expenses	138.89M	135.74M	135.18M	137.53M	109.50M	76.50M	27.51M	16.70M	12.41M	4.36M	3.39M
Interest Expense	14.71M	8.44M	17.44M	357.00K	284.00K	-	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	148.25M	143.40M	140.33M	138.54M	109.50M	78.31M	28.11M	16.73M	12.41M	4.36M	3.39M
Income Tax	3.92M	1.14M	1.45M	3.37M	-4.62M	125.00K	19.00K	-	-	81.00K	-
Shares Outstanding (Basic)	28.83M	22.81M	22.35M	21.78M	20.53M	15.75M	9.72M	11.97M	2.30M	2.30M	2.12M
Shares Outstanding (Diluted)	28.83M	22.81M	22.35M	21.78M	20.53M	15.75M	9.72M	11.97M	2.30M	2.30M	2.12M
EPS (Basic)	-3.55	-4.79	-4.96	-5.9	-4.9	-4.8	-2.06	-0.16	-5.51	-1.98	-1.56
EPS (Diluted)	-3.55	-4.79	-4.96	-5.9	-4.9	-4.8	-2.06	-0.16	-5.51	-1.98	-1.56
EBITDA	-63.83M	-78.03M	-90.15M	-122.71M	-108.15M	-77.18M	-19.74M	1.01M	-12.30M	-4.34M	-3.37M
Depreciation & Amortization	1.71M	1.82M	1.77M	2.04M	1.32M	417.00K	207.00K	213.00K	113.00K	30.00K	18.00K